These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 945141)

  • 1. A comparative study on in vitro cytotoxic reactions of lymphocytes from normal donors and patients with sarcomas to cultured tumor cells.
    Kay HD; Thota H; Sinkovics JG
    Clin Immunol Immunopathol; 1976 Mar; 5(2):218-34. PubMed ID: 945141
    [No Abstract]   [Full Text] [Related]  

  • 2. The concept of immunotherapy of human sarcomas: the need for an in vitro monitoring assay.
    Sinkovics JG; Campos LT; Kay HD; Loh KK; Cabiness JR; Ervin F
    Ann Clin Lab Sci; 1973; 3(6):414-23. PubMed ID: 4796444
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen.
    Cohen AM; Ketcham AS; Morton DL
    J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520
    [No Abstract]   [Full Text] [Related]  

  • 4. Host immunity to growing sarcomas: tumor-specific serum inhibition of tumor-specific cellular immunity.
    Cohen AM
    Cancer; 1973 Jan; 31(1):81-9. PubMed ID: 4509387
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxic lymphocytes. II. Antagonism and synergism between serum factors and lymphocytes of patients with sarcomas as tested against cultured tumor cells.
    Sinkovics JG; Ahmed N; Hrgovcic MJ; Cabiness JR; Wilbur JR
    Tex Rep Biol Med; 1972; 30(4):347-60. PubMed ID: 4121149
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunity and cancer: suppressor effect on the cytotoxic activity of lymphoid cells from animals carrying syngeneic tumors].
    Schaaf-Lafontaine N; Firket H
    C R Acad Hebd Seances Acad Sci D; 1977 May; 284(17):1741-3. PubMed ID: 406097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Cytotoxic lymphocytes from normal donors.
    Kay HD; Sinkovics JG
    Lancet; 1974 Aug; 2(7875):296-7. PubMed ID: 4136186
    [No Abstract]   [Full Text] [Related]  

  • 8. Alteration of in vitro anti-tumor activity of tumor-bearer sera by absorption with Staphylococcus aureus, Cowan I.
    Steele G; Ankerst J; Sjögren HO
    Int J Cancer; 1974 Jul; 14(1):83-92. PubMed ID: 4376510
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific anti-tumor responses by cultured immune spleen cells. II. Culture supernatants induce specific anti-tumor cytotoxicity by non-immune lymphoid cells in vitro.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Aug; 16(2):292-300. PubMed ID: 1150355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic or antgonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system.
    Skurzak HM; Klein E; Yoshida TO; Lamon EW
    J Exp Med; 1972 Apr; 135(4):997-1002. PubMed ID: 5018057
    [No Abstract]   [Full Text] [Related]  

  • 11. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH; Drogemuller CR; Pilch YH
    Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses of adenovirus type-9 infected (tumor-free) male rats against adenovirus type-9 induced mammary fibroadenomas and a chemically induced mammary carcinoma.
    Steele G; Ankerst J; Sjögren HO
    Int J Cancer; 1974 Sep; 14(3):359-66. PubMed ID: 4376519
    [No Abstract]   [Full Text] [Related]  

  • 13. Rejection of tumor cells in vitro.
    Berczi I; Strausbauch P; Sehon AH
    Science; 1973 Jun; 180(4092):1289-91. PubMed ID: 4122513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of variables affecting the measurement of tumor immunity in vitro with 125I-iododeoxyuridine-labelled target cells. Studies of immunity to primary Moloney sarcomas.
    Seeger RC; Rayner SA; Owen JJ
    Int J Cancer; 1974 May; 13(5):697-713. PubMed ID: 4367342
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
    Leclerc JC; Gomard E; Levy JP
    Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A; Gomard E; Plata F; Levy JP
    Int J Cancer; 1973 Jul; 12(1):233-41. PubMed ID: 4133585
    [No Abstract]   [Full Text] [Related]  

  • 17. Discussion paper: in vitro augmentation of tumor immunity in a murine methylcholanthrene sarcoma system.
    Yarlott MA; McKhann CF
    Ann N Y Acad Sci; 1976; 277(00):533-40. PubMed ID: 187102
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells and blocking by serum.
    Hellström I; Hellström KE
    Int J Cancer; 1975 Jan; 15(1):1-16. PubMed ID: 1168624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.